Bristol-Myers-BMY Said They Will Not Be the Buyer of ImClone-IMCL
Tweet Send to a Friend
In an amended 13D filing after the close, ImClone Systems' (NASDAQ: IMCL) drug-partner Bristol-Myers Squibb Co. (NYSE: BMY) said while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
